Nautilus Biotechnology

Neurons in Parkinson's disease
#Nautilus Biotechnology #Neurodegenerative disorders #Parkinson's #The Michael J Fox Foundation

$1.6m collaboration to advance Parkinson’s proteomics research 

A $1.6 million research effort is set to advance single-molecule proteomics research in Parkinson’s disease (PD).  Life sciences company Nautilus Biotechnology has partnered with Weill Cornell Medicine-Qatar (WCM-Q) and The Michael J Fox Foundation (MJFF) to study the connection between the alpha-synuclein (aSyn) protein and PD.   The project will combine WCM-Q’s lab expertise in… Read More

#Business & Investment #News

Proteomics
#Alzheimer's #Collaboration #Nautilus Biotechnology #Neuroscience #Partnership #Proteomics

Nautilus forms partnership to better understand Alzheimer’s

Proteome analysis company Nautilus Biotechnology has announced a partnership with the Allen Institute focused on improving our understanding of neurodegenerative conditions.  The organisations will investigate the connection between the tau protein and its occurrence in neurodegenerative conditions such as Alzheimer’s disease.  Recent studies suggested that the order, timing and extent… Read More

#Business & Investment #News